| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
14,363 |
13,514 |
$595K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
8,333 |
7,692 |
$316K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
3,723 |
3,149 |
$223K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
594 |
567 |
$205K |
| 80053 |
Comprehensive metabolic panel |
17,071 |
15,351 |
$142K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
859 |
815 |
$94K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,681 |
1,613 |
$58K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
15,534 |
14,025 |
$56K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
28 |
27 |
$51K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
469 |
423 |
$41K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,456 |
3,083 |
$34K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,665 |
1,477 |
$32K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
718 |
663 |
$29K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
595 |
568 |
$28K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,637 |
1,475 |
$28K |
| 70450 |
Computed tomography, head or brain; without contrast material |
473 |
445 |
$28K |
| 85027 |
|
3,030 |
2,721 |
$27K |
| 71046 |
Radiologic examination, chest; 2 views |
1,292 |
1,223 |
$22K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
513 |
167 |
$22K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,378 |
2,291 |
$21K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,253 |
609 |
$20K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,075 |
980 |
$20K |
| 71045 |
Radiologic examination, chest; single view |
3,393 |
3,055 |
$20K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
678 |
602 |
$18K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
855 |
769 |
$17K |
| 84484 |
|
2,400 |
2,023 |
$17K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
451 |
429 |
$17K |
| 80164 |
|
1,785 |
1,653 |
$16K |
| 87400 |
|
1,731 |
846 |
$15K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
469 |
101 |
$14K |
| 81001 |
|
3,566 |
3,290 |
$12K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
343 |
325 |
$11K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,209 |
1,116 |
$11K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
368 |
92 |
$10K |
| 84439 |
|
1,758 |
1,701 |
$8K |
| 86140 |
|
1,313 |
1,188 |
$8K |
| 87040 |
|
772 |
713 |
$8K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
79 |
78 |
$8K |
| G0378 |
Hospital observation service, per hour |
102 |
96 |
$8K |
| 87486 |
|
594 |
567 |
$7K |
| 87581 |
|
594 |
567 |
$7K |
| 85007 |
|
2,854 |
2,573 |
$7K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
112 |
99 |
$6K |
| 74019 |
|
335 |
303 |
$6K |
| 80305 |
|
553 |
522 |
$6K |
| 80061 |
Lipid panel |
791 |
769 |
$6K |
| 83605 |
|
917 |
819 |
$6K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,252 |
706 |
$6K |
| 83880 |
|
343 |
304 |
$5K |
| 81003 |
|
3,441 |
3,213 |
$4K |
| 83655 |
|
281 |
267 |
$4K |
| 83690 |
|
743 |
658 |
$4K |
| 87807 |
|
208 |
201 |
$4K |
| 87420 |
|
284 |
277 |
$4K |
| 81025 |
|
405 |
389 |
$3K |
| 80081 |
|
29 |
28 |
$3K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
1,883 |
1,731 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
295 |
290 |
$3K |
| 87070 |
|
343 |
329 |
$3K |
| 85610 |
|
886 |
757 |
$3K |
| 0240U |
|
23 |
18 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
347 |
341 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
208 |
166 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
22,410 |
19,006 |
$2K |
| 85730 |
|
703 |
643 |
$2K |
| 80306 |
|
142 |
137 |
$2K |
| 82728 |
|
100 |
99 |
$2K |
| 80074 |
|
83 |
81 |
$2K |
| 29580 |
|
30 |
13 |
$2K |
| 97597 |
|
27 |
14 |
$2K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
120 |
118 |
$2K |
| 86696 |
|
61 |
55 |
$2K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
44 |
38 |
$2K |
| 87634 |
|
30 |
25 |
$2K |
| 84146 |
|
110 |
108 |
$1K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
131 |
128 |
$1K |
| 85652 |
|
235 |
226 |
$1K |
| 86803 |
|
71 |
70 |
$1K |
| 87186 |
|
149 |
127 |
$1K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
95 |
86 |
$1K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
94 |
51 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
621 |
568 |
$1K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
124 |
117 |
$982.62 |
| 83721 |
|
206 |
197 |
$956.80 |
| 82607 |
|
132 |
127 |
$950.72 |
| 86850 |
|
122 |
118 |
$944.88 |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
881 |
726 |
$768.51 |
| 87077 |
|
113 |
100 |
$764.44 |
| 82746 |
|
97 |
95 |
$736.35 |
| 99070 |
|
170 |
91 |
$736.01 |
| 86901 |
|
125 |
120 |
$675.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
15 |
13 |
$586.35 |
| 73130 |
|
30 |
30 |
$579.70 |
| 86900 |
|
125 |
120 |
$533.28 |
| 97161 |
|
14 |
13 |
$523.11 |
| 86695 |
|
56 |
55 |
$494.36 |
| A0425 |
Ground mileage, per statute mile |
1,618 |
1,266 |
$488.18 |
| 83735 |
|
111 |
98 |
$485.89 |
| 87088 |
|
83 |
71 |
$480.05 |
| 82150 |
|
59 |
56 |
$471.33 |
| 83615 |
|
94 |
70 |
$467.52 |
| 84703 |
|
45 |
43 |
$448.39 |
| 73562 |
|
15 |
15 |
$356.55 |
| 97010 |
|
42 |
16 |
$327.25 |
| 73610 |
|
15 |
15 |
$309.45 |
| 80320 |
|
14 |
13 |
$238.93 |
| 84436 |
|
25 |
25 |
$222.71 |
| 82550 |
|
43 |
39 |
$220.36 |
| 72100 |
|
13 |
13 |
$211.38 |
| 73030 |
|
12 |
12 |
$204.25 |
| 87340 |
|
13 |
13 |
$197.31 |
| 93017 |
|
12 |
12 |
$186.78 |
| 84702 |
|
13 |
12 |
$136.30 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,400 |
1,216 |
$135.36 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
167 |
151 |
$129.15 |
| 85018 |
|
74 |
70 |
$125.33 |
| 84466 |
|
13 |
13 |
$122.30 |
| 86787 |
|
13 |
12 |
$119.69 |
| 86762 |
|
12 |
12 |
$111.90 |
| 82950 |
|
13 |
13 |
$108.15 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
26 |
24 |
$104.47 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
158 |
147 |
$100.66 |
| 86592 |
|
14 |
14 |
$85.40 |
| 83540 |
|
28 |
27 |
$72.34 |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
30 |
24 |
$53.76 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
72 |
70 |
$47.58 |
| 84550 |
|
16 |
15 |
$41.85 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
53 |
50 |
$37.21 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
14 |
13 |
$36.42 |
| 82948 |
|
14 |
12 |
$20.79 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
27 |
26 |
$15.19 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
16 |
12 |
$13.29 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
21 |
14 |
$9.19 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
12 |
12 |
$6.87 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
48 |
47 |
$0.62 |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
38 |
27 |
$0.33 |
| 84479 |
|
14 |
14 |
$0.31 |
| P9603 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled |
151 |
108 |
$0.20 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
150 |
145 |
$0.00 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
398 |
358 |
$0.00 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
25 |
13 |
$0.00 |
| A9270 |
Non-covered item or service |
496 |
309 |
$0.00 |